Free Trial
NASDAQ:MDBH

MDB Capital Q2 2025 Earnings Report

MDB Capital logo
$3.25 -0.03 (-0.85%)
Closing price 03:59 PM Eastern
Extended Trading
$3.24 -0.01 (-0.22%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MDB Capital EPS Results

Actual EPS
-$0.83
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

MDB Capital Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

MDB Capital Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

MDB Capital's Q2 2025 earnings is scheduled for Wednesday, August 27, 2025, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Conference Call Resources

MDB Capital Earnings Headlines

Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
MDB Capital Holdings LLC (MDBH) - Investing.com
See More MDB Capital Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like MDB Capital? Sign up for Earnings360's daily newsletter to receive timely earnings updates on MDB Capital and other key companies, straight to your email.

About MDB Capital

MDB Capital (NASDAQ:MDBH), through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business. The company was founded in 1997 and is based in Addison, Texas.

View MDB Capital Profile

More Earnings Resources from MarketBeat